Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis.
JAMA Oncol
; 4(3): e174519, 2018 Mar 08.
Article
in En
| MEDLINE
| ID: mdl-29285538
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oligopeptides
/
Cardiovascular Diseases
/
Proteasome Inhibitors
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Aged
/
Aged80
/
Humans
/
Middle aged
Language:
En
Journal:
JAMA Oncol
Year:
2018
Document type:
Article
Country of publication: